Literature DB >> 9122636

Serology of chlamydia in relation to asthma and bronchial hyperresponsiveness.

E Bjornsson1, E Hjelm, C Janson, E Fridell, G Boman.   

Abstract

Antibodies to the 3 strains of chlamydia were measured in the sera of 197 subjects; 122 with asthma-related symptoms and 75 from the general population. The subjects underwent a structured interview, spirometry, a methacholine provocation test and skin-prick tests. For chlamydia antibodies, IgG titer values of > or = 1:512 and/or IgM > or = 1:16 were regarded as evidence of a current or recent infection while IgG levels < 1:512 and > 1:32 were regarded as indicative of a previous infection. For Chlamydia pneumoniae, a relationship was found between current or recent infection and wheezing (odds ratio (OR) 6.0, confidence intervals (CI) 1.3-28) and also between IgA antibodies and bronchial hyperresponsiveness (BHR) (OR 3.3, CI 1.3-8.3). For Chlamydia trachomatis, serological signs of a previous infection were found significantly more often in subjects who reported having had asthma at some time: (OR 3.2, CI 1.4-7.1), asthma during the last year (OR 3.2, CI 1.4-7.1), wheezing during the last year (OR 4.2, CI 1.6-6.6) and in those who had BHR (OR 2.7, CI 1.2-6.1). We conclude that a relationship may exist between Chlamydia pneumoniae and Chlamydia trachomatis infections and asthma-related symptoms and BHR.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9122636     DOI: 10.3109/00365549609027152

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  6 in total

1.  Replicate PCR testing and probit analysis for detection and quantitation of Chlamydia pneumoniae in clinical specimens.

Authors:  M Smieja; J B Mahony; C H Goldsmith; S Chong; A Petrich; M Chernesky
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

2.  Persistent Chlamydia Pneumoniae serology is related to decline in lung function in women but not in men. Effect of persistent Chlamydia pneumoniae infection on lung function.

Authors:  Thorarinn Gislason; Vilmundur Guðdnason; Bryndis Benediktsdottir; Isleifur Olafsson; Thor Aspelund; Bjarni Thjodleifsson; Christer Janson
Journal:  BMC Pulm Med       Date:  2010-08-25       Impact factor: 3.317

3.  Secondary outcomes of a pilot randomized trial of azithromycin treatment for asthma.

Authors:  David L Hahn; Mary Beth Plane; Olaimatu S Mahdi; Gerald I Byrne
Journal:  PLoS Clin Trials       Date:  2006-06-30

Review 4.  The role of antibiotics in asthma.

Authors:  Francesco Blasi; Sebastian L Johnston
Journal:  Int J Antimicrob Agents       Date:  2007-03-13       Impact factor: 5.283

5.  Chlamydiae and Mycoplasma infections in pulmonary MALT lymphoma.

Authors:  E Chanudet; P Adam; A G Nicholson; A C Wotherspoon; R Ranaldi; G Goteri; S A Pileri; H Ye; H K Müller-Hermelink; M-Q Du
Journal:  Br J Cancer       Date:  2007-09-18       Impact factor: 7.640

6.  Toll-like receptor ligands LPS and poly (I:C) exacerbate airway hyperresponsiveness in a model of airway allergy in mice, independently of inflammation.

Authors:  Magnus Starkhammar; Olivia Larsson; Susanna Kumlien Georén; Marina Leino; Sven-Erik Dahlén; Mikael Adner; Lars-Olaf Cardell
Journal:  PLoS One       Date:  2014-08-04       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.